Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Allergy Wiley

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients

Loading next page...
1
 
/lp/wiley/lolium-perenne-peptide-immunotherapy-is-well-tolerated-and-elicits-a-N8QCfPHGmJ

References (70)

Publisher
Wiley
Copyright
Copyright © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
ISSN
0105-4538
eISSN
1398-9995
DOI
10.1111/all.13392
Publisher site
See Article on Publisher Site

Abstract

Journal

AllergyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

There are no references for this article.